Davita - Degray Kidney Ctr is a medicare approved dialysis facility center in Arkadelphia, Arkansas and it has 17 dialysis stations. It is located in Clark county at 312 Professional Park Dr Ste H, Arkadelphia, AR, 71923. You can reach out to the office of Davita - Degray Kidney Ctr at (870) 246-3021. This dialysis clinic is managed and/or owned by Davita. Davita - Degray Kidney Ctr has the following ownership type - Profit. It was first certified by medicare in September, 1986. The medicare id for this facility is 042512 and it accepts patients under medicare ESRD program.
Name | Davita - Degray Kidney Ctr |
---|---|
Location | 312 Professional Park Dr Ste H, Arkadelphia, Arkansas |
No. of Dialysis Stations | 17 |
Medicare ID | 042512 |
Managed By | Davita |
Ownership Type | Profit |
Late Shifts | No |
312 Professional Park Dr Ste H, Arkadelphia, Arkansas, 71923 | |
(870) 246-3021 | |
News Archive
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Charles Ebikeme, a writer for the All Results Journals who has worked as a research scientist on African sleeping sickness, examines a "blurring" link between non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing, "The topsy-turvy nature of NTDs extends far beyond infectious diseases and is becoming increasingly more complicated."
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
› Verified 2 days ago
NPI Number | 1184968604 |
Organization Name | Degray Dialysis |
Doing Business As | Renal Treatment Centers Southeast Lp |
Address | 312 Professional Park Dr Arkadelphia, Arkansas, 71923 |
Phone Number | (870) 246-3021 |
News Archive
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Charles Ebikeme, a writer for the All Results Journals who has worked as a research scientist on African sleeping sickness, examines a "blurring" link between non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing, "The topsy-turvy nature of NTDs extends far beyond infectious diseases and is becoming increasingly more complicated."
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
› Verified 2 days ago
NPI Number | 1982679916 |
Organization Name | Degray Kidney Center |
Doing Business As | Arkansas Nephrology Services, Ltd. |
Address | 312 Professional Park Dr Arkadelphia, Arkansas, 71923 |
Phone Number | (870) 246-3021 |
News Archive
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Charles Ebikeme, a writer for the All Results Journals who has worked as a research scientist on African sleeping sickness, examines a "blurring" link between non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing, "The topsy-turvy nature of NTDs extends far beyond infectious diseases and is becoming increasingly more complicated."
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
› Verified 2 days ago
Dialysis patients with Hemoglobin data | 42 |
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 19 |
News Archive
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Charles Ebikeme, a writer for the All Results Journals who has worked as a research scientist on African sleeping sickness, examines a "blurring" link between non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing, "The topsy-turvy nature of NTDs extends far beyond infectious diseases and is becoming increasingly more complicated."
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 69 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 590 |
Percentage of adult patients getting regular hemodialysis at the center | 92 |
News Archive
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Charles Ebikeme, a writer for the All Results Journals who has worked as a research scientist on African sleeping sickness, examines a "blurring" link between non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing, "The topsy-turvy nature of NTDs extends far beyond infectious diseases and is becoming increasingly more complicated."
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Degray Kidney Ctr with elevated calcium levels.
Patients with hypercalcemia | 72 |
Hypercalcemia patient months | 626 |
Patients with Serumphosphor | 74 |
Patients with Serumphosphor less than 3.5 mg/dL | 6 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 18 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 38 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 20 |
Patients with Serumphosphor greater than 7 mg/dL | 17 |
News Archive
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Charles Ebikeme, a writer for the All Results Journals who has worked as a research scientist on African sleeping sickness, examines a "blurring" link between non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing, "The topsy-turvy nature of NTDs extends far beyond infectious diseases and is becoming increasingly more complicated."
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 64 |
Patient months included in arterial venous fistula and catheter summaries | 504 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 75 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 6 |
News Archive
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Charles Ebikeme, a writer for the All Results Journals who has worked as a research scientist on African sleeping sickness, examines a "blurring" link between non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing, "The topsy-turvy nature of NTDs extends far beyond infectious diseases and is becoming increasingly more complicated."
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 50 |
Hospitalization Rate in facility | 94.3 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 192.1 |
Hospitalization Rate: Lower Confidence Limit | 48.6 |
News Archive
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Charles Ebikeme, a writer for the All Results Journals who has worked as a research scientist on African sleeping sickness, examines a "blurring" link between non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing, "The topsy-turvy nature of NTDs extends far beyond infectious diseases and is becoming increasingly more complicated."
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita - Degray Kidney Ctr were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 11.6 (As Expected) |
Readmission Rate: Upper Confidence Limit | 24.8 |
Readmission Rate: Lower Confidence Limit | 4 |
News Archive
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Charles Ebikeme, a writer for the All Results Journals who has worked as a research scientist on African sleeping sickness, examines a "blurring" link between non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing, "The topsy-turvy nature of NTDs extends far beyond infectious diseases and is becoming increasingly more complicated."
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Degray Kidney Ctr get infections in their blood each year compared to the number of infections expected for the center based on the national average.
Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
Infection Rate in facility | .3 (As Expected) |
SIR: Upper Confidence Limit | 1.49 |
SIR: Lower Confidence Limit | .02 |
News Archive
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Charles Ebikeme, a writer for the All Results Journals who has worked as a research scientist on African sleeping sickness, examines a "blurring" link between non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing, "The topsy-turvy nature of NTDs extends far beyond infectious diseases and is becoming increasingly more complicated."
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Degray Kidney Ctr's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
Patients in facility's Transfusion Summary | 41 |
Transfusion Rate in facility | 34.3 (As Expected) |
Transfusion Rate: Upper Confidence Limit | 99.4 |
Transfusion Rate: Lower Confidence Limit | 13.5 |
News Archive
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Charles Ebikeme, a writer for the All Results Journals who has worked as a research scientist on African sleeping sickness, examines a "blurring" link between non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing, "The topsy-turvy nature of NTDs extends far beyond infectious diseases and is becoming increasingly more complicated."
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita - Degray Kidney Ctr lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
Patients in facility's Survival Summary | 280 |
Mortality Rate in facility | 17.7 (As Expected) |
Mortality Rate: Upper Confidence Limit | 23.7 |
Mortality Rate: Lower Confidence Limit | 12.8 |
News Archive
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Charles Ebikeme, a writer for the All Results Journals who has worked as a research scientist on African sleeping sickness, examines a "blurring" link between non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing, "The topsy-turvy nature of NTDs extends far beyond infectious diseases and is becoming increasingly more complicated."
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
› Verified 2 days ago
Davita - Degray Kidney Ctr Location: 312 Professional Park Dr Ste H, Arkadelphia, Arkansas, 71923 Phone: (870) 246-3021 |
News Archive
Researchers have developed a type of wearable, non-invasive electronic device that can monitor vital signs such as heart rate and respiration at the same time it records a person's activity level, opening new opportunities for biomedical research, diagnostics and patient care.
In this post in the Global Network for Neglected Tropical Diseases' "End the Neglect" blog, Charles Ebikeme, a writer for the All Results Journals who has worked as a research scientist on African sleeping sickness, examines a "blurring" link between non-communicable diseases (NCDs) and neglected tropical diseases (NTDs), writing, "The topsy-turvy nature of NTDs extends far beyond infectious diseases and is becoming increasingly more complicated."
The use of implanted defibrillators that keep the heart beating in proper electrical rhythm to prevent cardiac arrest appears to be cost-effective for those patients who receive a significant mortality reduction, according to researchers from Duke Clinical Research Institute (DCRI), Stanford University and the VA Palo Alto Health Care System, Calif. They analyzed eight clinical trials of the devices to arrive at their conclusion.
Many patients see their tumors shrink in response to a drug, only to have them come back with a vengeance as they evolve to fend off the treatment. Oncologists want to be able to quickly detect cancer drug resistance as it emerges in their patients and identify another drug the tumors will still respond to.
Massachusetts health care officials this month are boosting efforts to enroll low-income residents in subsidized health insurance plans as the state approaches the Dec. 31 deadline for all residents to obtain coverage or face tax penalties, the Boston Globe reports.
› Verified 2 days ago